TL;DR: Aetna modified CPB 0330 for the Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT), effective September 26, 2025. Here's what billing teams need to act on now.
Aetna, a CVS Health company, updated its Aetna MSLT and MWT coverage policy under CPB 0330 Aetna system, narrowing the covered indications to two specific diagnostic scenarios and setting strict limits on repeat testing. CPT 95805 is the primary code at stake. If your sleep center or neurology practice bills Aetna for MSLT or MWT services, this policy defines exactly when you get paid — and when you don't.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT) |
| Policy Code | CPB 0330 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | Sleep medicine, neurology, pulmonology, psychiatry |
| Key Action | Audit all pending and upcoming MSLT/MWT claims billed under CPT 95805 against the two covered indications before September 26, 2025 |
Aetna MSLT and MWT Coverage Criteria and Medical Necessity Requirements 2025
The Aetna MSLT and MWT coverage policy is tight. Two indications qualify for medical necessity coverage under CPB 0330. Everything else is a denial waiting to happen.
Aetna covers CPT 95805 — multiple sleep latency or maintenance of wakefulness testing, recording, analysis, and interpretation — when the test is used to evaluate symptoms of narcolepsy and confirm the diagnosis. That's indication one. Indication two: evaluating patients with suspected idiopathic hypersomnia to differentiate it from narcolepsy. Both are ICD-10 territory you'll find in the G47.4xx and G47.1x code ranges.
That second indication matters. Idiopathic hypersomnia (G47.10–G47.19) is on the covered list, but only when the clinical question is whether the patient has hypersomnia or narcolepsy. Billing for hypersomnia evaluation alone — without that differential diagnosis framing — is a different clinical situation. Your documentation needs to reflect the diagnostic question being answered.
The medical necessity standard here is narrower than what some billing teams assume. A patient with excessive daytime sleepiness, general fatigue, or a suspected circadian disorder doesn't automatically qualify. The policy requires a clear path toward either a narcolepsy confirmation or an idiopathic hypersomnia-versus-narcolepsy workup. If your physician's order and clinical notes don't show that, you're exposed.
Prior authorization requirements aren't explicitly called out in this policy update, but that doesn't mean you skip it. Aetna routinely requires prior auth for sleep studies under this CPB. Verify auth requirements by plan type before you schedule the test — not after you bill it.
Aetna MSLT and MWT Repeat Testing: When It's Covered and When It Isn't
Repeat MSLT and MWT testing is not medically necessary by default. Aetna is explicit about that. If a patient already had a test, you need a documented reason that falls into one of three specific exceptions.
Exception one: the initial test was invalid or uninterpretable. Exception two: extraneous circumstances affected the initial test, or study conditions weren't met during the initial session. Exception three: the patient is suspected to have narcolepsy, but the earlier MSLT or MWT didn't produce polygraphic confirmation.
That third exception is the one most billing teams will use. Narcolepsy without polygraphic confirmation — meaning the test didn't capture the clinical findings needed to confirm the diagnosis — is a legitimate repeat indication. But your documentation has to carry the argument. The prior test results, the reason for inconclusiveness, and the clinical rationale for repeating must all be in the record.
If a repeat test doesn't fit one of these three boxes, Aetna considers it not medically necessary. Billing it anyway means a claim denial and potential recoupment exposure. Talk to your compliance officer before billing repeat studies if the documentation is thin.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Narcolepsy evaluation and diagnosis confirmation | Covered | CPT 95805; G47.411–G47.414 | Must be used to confirm suspected narcolepsy |
| Suspected idiopathic hypersomnia — differentiating from narcolepsy | Covered | CPT 95805; G47.10–G47.19 | Differential diagnosis framing required in documentation |
| Repeat MSLT/MWT — initial test invalid or uninterpretable | Covered (exception) | CPT 95805 | Document reason for invalidity |
| Repeat MSLT/MWT — extraneous circumstances affected initial study | Covered (exception) | CPT 95805 | Document study conditions and what was compromised |
| Repeat MSLT/MWT — narcolepsy suspected but no polygraphic confirmation on initial test | Covered (exception) | CPT 95805 | Prior test results and clinical rationale required |
| MSLT/MWT for other sleep disorders (circadian rhythm, insomnia, sleep apnea, etc.) | Not covered | — | Not a listed indication under CPB 0330 |
| Routine repeat MSLT/MWT without exception criteria | Not covered | — | No documented exception = denial |
Aetna MSLT and MWT Billing Guidelines and Action Items 2025
The effective date is September 26, 2025. Here's what to do before and after that date.
| # | Action Item |
|---|---|
| 1 | Audit your CPT 95805 claim queue now. Pull all pending and upcoming MSLT/MWT claims and check each one against the two covered indications. If the diagnosis doesn't point to narcolepsy confirmation or a narcolepsy-versus-idiopathic-hypersomnia workup, flag it for clinical review before billing. |
| 2 | Update your charge capture workflow for repeat testing. Add a documentation checkpoint for any repeat MSLT or MWT order. The ordering provider needs to document which of the three exceptions applies — before the test runs, not after you get a denial. |
| 3 | Review ICD-10 code assignment on MSLT/MWT claims. The policy supports a wide ICD-10 list (see the code table below), but inclusion on the list doesn't mean automatic coverage. The diagnosis code must align with the two covered clinical scenarios. G47.411 (narcolepsy with cataplexy) and G47.10–G47.19 (hypersomnia codes) are your primary diagnosis codes for covered claims. |
| 4 | Verify prior authorization requirements by Aetna plan type. CPB 0330 is the clinical policy, but prior auth rules vary by product — HMO, PPO, and commercial plans may differ. Check authorization requirements through Aetna's provider portal before scheduling, not after billing. |
| 5 | Train your sleep medicine schedulers and clinical staff on the two covered indications. Billing follows documentation. If the ordering note doesn't establish the right clinical question, the claim fails. This is a front-end fix, not a back-end one. |
| 6 | Consult your compliance officer if you have mixed-indication cases. Some patients present with both narcolepsy symptoms and comorbid conditions like sleep apnea (G47.33) or restless legs syndrome (G25.81). Those comorbidities appear in the CPB's broader ICD-10 list, but they don't expand the covered indications. If your patient mix includes complex cases, get compliance input before September 26, 2025. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for MSLT and MWT Under CPB 0330
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 95805 | CPT | Multiple sleep latency or maintenance of wakefulness testing, recording, analysis and interpretation |
Key ICD-10-CM Diagnosis Codes
The full ICD-10 list in CPB 0330 runs 99 codes. That's a broad diagnostic universe, but remember: code presence on the list doesn't equal automatic MSLT/MWT reimbursement. Coverage still hinges on the two clinical indications.
| Code | Description |
|---|---|
| G47.411 | Narcolepsy with cataplexy |
| G47.412 | Narcolepsy with cataplexy |
| G47.413 | Narcolepsy with cataplexy |
| G47.414 | Narcolepsy with cataplexy |
| G47.10 | Hypersomnia, unspecified |
| G47.11 | Idiopathic hypersomnia with long sleep time |
| G47.12 | Idiopathic hypersomnia without long sleep time |
| G47.13 | Recurrent hypersomnia |
| G47.14 | Hypersomnia due to medical condition |
| G47.15 | Hypersomnia, unspecified |
| G47.16 | Hypersomnia |
| G47.17 | Hypersomnia |
| G47.18 | Hypersomnia |
| G47.19 | Hypersomnia |
| G47.00 | Insomnia, unspecified |
| G47.30 | Sleep apnea, unspecified |
| G47.33 | Obstructive sleep apnea (adult) (pediatric) |
| G47.20–G47.29 | Circadian rhythm sleep disorders |
| G25.81 | Restless legs syndrome |
| F51.01 | Primary insomnia |
| F51.03 | Paradoxical insomnia |
| F51.09 | Other insomnia not due to a substance or known physiological condition |
| F51.13 | Hypersomnia due to other mental disorder |
| F51.5 | Nightmare disorder |
| F90.0–F90.9 | Attention-deficit hyperactivity disorders |
| F51.13 | Hypersomnia due to mental disorder |
| G30.0–G30.9 | Alzheimer's disease |
| G31.09 | Other frontotemporal dementia |
| G31.83 | Dementia with Lewy bodies |
| G20.A1–G20.C | Parkinson's disease |
| G21.11–G21.3 | Other drug-induced secondary parkinsonism |
| G21.4 | Vascular parkinsonism |
| G21.8 | Other and unspecified secondary parkinsonism |
| G21.9 | Other and unspecified secondary parkinsonism |
| F01.50–F03.918 | Dementias |
| F02.80–F02.818 | Dementia in conditions classified elsewhere |
| F03.90–F03.918 | Unspecified dementia |
| F10.27 | Alcohol dependence with alcohol-induced persisting dementia |
| F13.27 | Sedative/hypnotic drug-induced persisting dementia |
| F13.97 | Drug-induced persisting dementia |
| F18.17 | Inhalant-induced persisting dementia |
| F18.27 | Drug-induced persisting dementia |
| F18.97 | Drug-induced persisting dementia |
| F19.17 | Other psychoactive substance-induced persisting dementia |
| F19.27 | Drug-induced persisting dementia |
| F19.97 | Drug-induced persisting dementia |
The dementia, Parkinson's, and ADHD codes on this list reflect the broader clinical context in which sleep disorders appear — not expanded indications for MSLT/MWT coverage. Don't use a dementia or ADHD diagnosis as your primary claim driver for CPT 95805. The covered indication still has to be narcolepsy evaluation or the hypersomnia-versus-narcolepsy differential.
Get the Full Picture for CPT 95805
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.